By 2022, the global population will top 8 billion people, up from less than 4.5 billion a mere 40 years ago. In the U.S., the population is approaching 340 million, up more than 100 million. Meanwhile, the median age in the U.S. has risen 10 years in the past 45 years. That growing and aging population brings new challenges to our healthcare infrastructure as well as strong demand for breakthroughs in life sciences, health monitoring, diagnostics, and therapeutics.
Fortunately, technology’s positive trajectory in advanced computing, rapid and high-fidelity detection schemes, and novelties in AI-inspired tools, provides excellent opportunities to translate those improvements and create positive impacts on life sciences and human health.
Triton has a rich history of developing novel diagnostic and detection tools and monitoring sensors that are useful in a range of applications, from biomarker-based detection and optoelectronic-based cardiac ventricular devices to cloud-based chronic disease monitoring and novel “organs on a chip” for high-throughput drug discovery applications.